Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING ACTIVE PRINCIPLES

RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING ACTIVE PRINCIPLES

US Patent 6841358 · Granted Jan 11, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for use in treatment of acne2025
Bordetella strains expressing serotype 3 fimbriae2025
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2023
Bordetella strains expressing serotype 3 fimbriae2022
Attenuated Bordetella strains2022
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2021
Mutant Bordetella strains and methods of use2021
Mutant Bordetella strains and methods of use2020
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2020
Attenuated Bordetella strains2020
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology2019
Prevention of pertussis using adenylate cyclase deficient Bordetella strains2019